Skip to main content
. Author manuscript; available in PMC: 2009 Jul 7.
Published in final edited form as: Exp Hematol. 2007 Apr;35(4 Suppl 1):78–86. doi: 10.1016/j.exphem.2007.01.028

Figure 6.

Figure 6

Wild-type littermate control (WT) but not IL-31R-/- myeloid progenitor cells are responsive in vitro the survival enhancing effects of IL-31 in the context of delayed growth factor addition. Bone marrow cells were plated at 5×104/ml in the presence of control diluent, SDF-1/CXCL12 (100ng/ml) or Il-31 (100ng/ml) in the presence of hemin. A combination of EPO (1U/ml) PWMSCM (5% vol/vol) and SCF (50ng/ml) were added to plates at either day 0, 1 or 2.